Try our Advanced Search for more refined results

June 09, 2020

BIAL - PORTELA & CA. S.A. et al v. Alkem Laboratories Limited

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 16, 2022

    Judge Axes 2 Anti-Seizure Drug Patents, Upholds 3 Others

    A Delaware federal judge has found that claims in a pair of patents related to epileptic seizure treatment Aptiom were invalid, while at the same time finding that patent challenger Alkem failed to prove that other patents on the product were invalid.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login